The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review Jayne S. WilsonCaroline MainBarry Pizer Review Open access 31 January 2024 Pages: 1 - 34
Correction to: The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review Jayne S. WilsonCaroline MainBarry Pizer Correction Open access 05 March 2024 Pages: 35 - 37
Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review Eric SinghMuhammet Enes GursesAshish H. Shah Review 31 January 2024 Pages: 39 - 47
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review Eric SinghMuhammet Enes GursesAshish H. Shah Correction 06 March 2024 Pages: 49 - 49
Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery Motoyuki UmekawaYuki ShinyaNobuhito Saito Research Open access 18 February 2024 Pages: 51 - 61
CPLX2 is a novel tumor suppressor and improves the prognosis in glioma Yuanbing ChenJieling NingJun Huang Research 01 March 2024 Pages: 63 - 74
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma Yukina ShiraiToshihide UenoShinji Kohsaka Research Open access 16 February 2024 Pages: 75 - 88
Validation of a methylation-based signature for subventricular zone involvement in glioblastoma Felix EhretOliver ZühlkeDavid Kaul Research Open access 20 February 2024 Pages: 89 - 97
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype Antonio DonoJose TorresYoshua Esquenazi Research 13 February 2024 Pages: 99 - 109
Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes Thais Baccili Cury MegidZeynep BaskurtElena Elimova Research Open access 19 February 2024 Pages: 111 - 122
Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study Bin WangYimei LiuXiaowu Deng Research Open access 01 February 2024 Pages: 123 - 132
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas Naureen KericHarald KrenzlinFlorian Ringel Research Open access 07 February 2024 Pages: 133 - 144
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study Vincenzo Di NunnoGiuseppe LombardiEnrico Franceschi Research 08 March 2024 Pages: 145 - 154
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection David WasilewskiJulia OnkenPhilip Bischoff Research Open access 15 February 2024 Pages: 155 - 167
Effect of sarcopenia and frailty on outcomes among patients with brain metastases Mervyn Jun Rui LimZheting ZhangTseng Tsai Yeo Case Study 02 March 2024 Pages: 169 - 180
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab Pushan DasguptaAlexander OuNazanin K. Majd Case Study 19 February 2024 Pages: 181 - 188
CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization Manali RanadeSridhar EpariTejpal Gupta Case Study 24 January 2024 Pages: 189 - 198
Correction to: CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization Manali RanadeSridhar EpariTejpal Gupta Correction 15 February 2024 Pages: 199 - 199
Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review Yasuhito KegoyaYoshihiro OtaniIsao Date Case Study Open access 01 March 2024 Pages: 201 - 210
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors Lisa M. ArnoldYoji HoshinaJoe Mendez Case Study 16 February 2024 Pages: 211 - 217
Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery Andrew FairchildJoseph K. SalamaScott R. Floyd Case Study 10 February 2024 Pages: 219 - 227
Stereotactic radiosurgery for intracranial adenoid cystic carcinoma Jason P. SheehanRaj SinghDaniel M. Trifiletti Correspondence 16 February 2024 Pages: 229 - 230
Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma Jason P. SheehanGeorgios MantziarisAdomas Bunevicius Correspondence 16 February 2024 Pages: 231 - 232